Fellow - Laboratory Genetics and Genomics
Dr. Butler’s work has focused on the genetic basis of neurological disease. She received her Ph.D. in genetics and molecular biology from Emory University
where she evaluated and functionally tested novel variants detected from individuals with epilepsy. Dr. Butler joined GGC in the summer of 2018 as
a fellow in the Laboratory Genetics and Genomics training program. She is training in implementation and interpretation of both molecular and cytogenetic
diagnostic tests, as well as the development and validation of novel assays for use in clinical settings.
Fax (864) 941-8141
- B.S., Genetics, Clemson University, Clemson, SC, 2013
- Ph.D., Genetics and Molecular Biology, Emory University, Atlanta, GA, 2018
- Fellow, Laboratory Genetics and Genomics, Greenwood Genetic Center, 2018-present
Mattison KA*, Butler KM*, Inglis GAS, Dayan O, Boussidan H, Bambhani V, Philbrook B, da Silva C, Alexander JJ, Kanner BI, Escayg A. SLC6A1
variants identified in epilepsy patients reduce γ-aminobutyric acid transport. Epilepsia, 2018 Aug 21 * equal contribution
- Butler KM, Moody O, Schuler E, Coryell J, Alexander JJ, Jenkins A, Escayg A. De novo variants in GABRA2 and GABRA5 alter receptor
function and contribute to early-onset epilepsy. Brain, 2018 (Accepted)
- Butler KM, da Silva C, Alexander JJ, Hegde M, Escayg A. Diagnostic yield from 339 epilepsy patients screened on a clinical gene panel.
Pediatric Neurology, 77, 2017, pp 61-66.
- Butler KM, da Silva C, Shafir Y, Weisfeld-Adams JD, Alexander JJ, Hegde M, Escayg A. De novo and inherited SCN8A epilepsy mutations
detected by gene panel analysis. Epilepsy Research, vol. 129, 2017, pp 17-25